Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
LONDON, Feb 3 (Reuters) - Data that shows 92% efficacy of Russia's Sputnik V vaccine is welcome, and more studies should be done to show if giving doses of different vaccines can be effective, AstraZeneca's research chief said on Wednesday.Clinica...
Read moreLONDON, Feb 3 (Reuters) - AstraZeneca and Oxford University aim to produce the next generation of COVID-19 vaccines that will protect against variants as soon as the autumn, a senior executive at the British drugmaker said on Wednesday.Asked when...
Read more
TOP NEWS SUMMARY: Vaccine Hope From GlaxoSmithKline And AstraZeneca
Read more(Recasts and updates throughout after COVAX publishes plan)By Stephanie Nebehay and Kate KellandGENEVA/LONDON, Feb 3 (Reuters) - The COVAX vaccine-sharing facility has allocated at least 330 million doses of COVID-19 vaccines for poorer countries a...
Read more(Adds details, background)GENEVA, Feb 3 (Reuters) - Figures for the doses of COVID-19 vaccines being allocated mainly to 92 low- and middle-income countries by June from the international COVAX scheme will be published on Wednesday, agencies said....
Read moreGENEVA, Feb 3 (Reuters) - Figures for the doses of COVID-19 vaccines being allocated mainly to 92 low- and middle-income countries from the COVAX facility in the first and second quarter of 2021 will be published on Wednesday, agencies said.The GA...
Read moreBy Alistair Smout and Sarah YoungLONDON, Feb 3 (Reuters) - Britain's health minister on Wednesday defended the country's vaccine roll-out strategy after scepticism emerged in Europe, saying the science supported a decision to give the shot develop...
Read more* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh* Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9HvBy Joice AlvesLONDON, Feb 3 (Reuters) - Sterling clung to gains against the euro on Wednesday but edged lower agai...
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* GlaxoSmithKline slumps on COVID-19 vaccine development* Vodafone gains after earnings beat estimates* Glencore rises after maintaining 2021...
Read moreLONDON, Feb 3 (Reuters) - Britain's health secretary said that scientists had shown the Oxford/AstraZeneca vaccine worked well, when asked about reported comments made by French President Emmanuel Macron that is "quasi-ineffective" among people o...
Read moreLONDON, Feb 3 (Reuters) - British Health Secretary Matt Hancock said he was confident that measures being taken in affected parts of the country to contain the spread of the South African variant would be successful."I'm confident that it can be,"...
Read moreLONDON, Feb 3 (Reuters) - Britain's health secretary said that new research meant that there was a high degree of confidence that the Oxford/ AstraZeneca vaccine works for all ages, after some countries said they would not give it to older age gr...
Read moreLONDON, Feb 3 (Reuters) - The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford's vaccine trial chief Andrew Pollard said ...
Read moreLONDON, Feb 3 (Reuters) - COVID-19 vaccines might offer protection against severe disease even as coronavirus variants evolve to better allow continued transmission between people, the head of the Oxford Vaccine Group Andrew Pollard said on Wedne...
Read morePARIS, Feb 3 (Reuters) - The United Kingdom has taken "enormous risks" regarding its COVID-19 vaccines strategy, said French European Affairs Minister Clement Beaune, as he defended the comparatively slower pace of vaccines rollout in France and ...
Read more
Last checked at